MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tauopathies"

  • MDS Virtual Congress 2021

    Lateralized Tau Pathology in a Case of Lewy Body Dementia with Corticobasal Syndrome

    D. Coughlin, H. Coslett, C. Mcmillan, J. Phillips, E. Lee, J. Trojanowski, M. Grossman, D. Irwin (San Diego, USA)

    Objective: To measure bilateral in vivo and postmortem tau pathology in a well-characterized patient presenting with corticobasal syndrome (CBS) due to underlying neocortical stage Lewy…
  • MDS Virtual Congress 2021

    MAPT mutation frontotemporal dementia with parkinsonism: when previous results can skew the diagnosis

    R. Franco, TC. Aguiar, A. Morganho, P. Lobo, R. Dias, S. Aguiar (Funchal, Portugal)

    Objective: Case report presentation. Background: In frontotemporal dementia with parkinsonism (FTDP), several mutations in MAPT gene have been identified, and numerous family cases were reported,…
  • MDS Virtual Congress 2020

    Long and short survival in Parkinson syndrome: pathology and genetics are key prognostic factors

    A. Rajput, C. Robinson, M. Farrer, E. Gustavsson, A. Rajput (Saskatoon, SK, Canada)

    Objective: To study the clinical, pathological and genetic profile of Parkinson syndrome (PS) cases that have > 20 years survival (long survival, or LS) compared…
  • MDS Virtual Congress 2020

    No frank biochemical evidence of proteinopathy in the cerebellar cortex of patients with essential tremor

    A. Rajput, A. Rajput, C. Tremblay, F. Calon, K. Melançon, E. Aubry-Lafontaine, E. Brochu, S. Paris-Robidas (Quebec, QC, Canada)

    Objective: This study was designed to determine the presence of common types of proteinopathies in the cerebellar cortex of patients who died with essential tremor…
  • MDS Virtual Congress 2020

    TAU pathology contributes to specific patterns of structural brain damage and neuropsychological heterogeneity in Huntington’s disease

    S. Martinez-Horta, J. Perez-Perez, R. Perez-Gonzalez, A. Horta-Barba, F. Sampedro, E. Rivas-Asensio, T. Xucla, M. Guasch, A. Campolongo, C. Izquierdo-Barrionuevo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: Explore the associations between CSF levels of neurofilament light chain (Nfl), total TAU (tTAU) and phosphorylated TAU (pTAU), structural brain damage and cognitive performance…
  • MDS Virtual Congress 2020

    Tau Neuropathology Associates with In Vivo Patterns of Neurodegeneration in Lewy Body Disorders

    N. Spotorno, D. Coughlin, L. Shaw, A. Chen-Plotkin, D. Weintraub, E. Lee, J. Trojanowski, C. McMillan, D. Irwin, M. Grossman (Philadelphia, PA, USA)

    Objective: Investigate the impact of Alzheimer’s disease (AD) co-pathology on an in vivo structural measure of neurodegeneration in Lewy Body disorders (LBD: Parkinson’s Disease and…
  • MDS Virtual Congress 2020

    Identification and characterization of anti-prionic compounds that disassemble Tau prions as a novel therapeutic approach for tauopathies

    D. Willbold, T. Altendorf, W. Hoyer, J. Mohrlüder (Jülich, Germany)

    Objective: Stabilization of monomeric Tau protein by transient and high-affinity binding ligands is a novel and highly innovative anti-prionic treatment strategy for tauopathies. Background: Tauopathies…
  • MDS Virtual Congress 2020

    Mixed pathologies in pancreatic beta-cells from subjects with neurodegenerative diseases and their interaction with prion protein

    R. Valenti, I. Martinez, I. Amat, I. Marcilla, G. Marti, L. Armengou, C. Caballero, M.R Luquin (Pamplona, Spain)

    Objective: We studied whether, as in the brain, pancreatic -cells of subjects with neurodegenerative diseases also present co-occurrence of other misfolded proteins. Furthermore, we also assessed…
  • MDS Virtual Congress 2020

    Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome

    I. Aiba, M. Yoshida, T. Shimohata, Y. Hayashi, T. Sano, Y. Saito, S. Murayama, K. Hasegawa, Y. Iwasaki, M. Sakai, K. Wakabayashi, T. Komori, K. Nakashima (Nagoya, Japan)

    Objective: To compare clinical features and natural course of corticobasal degeneration (CBD) presenting as corticobasal syndrome (CBD-CBS) and progressive supranuclear palsy presenting as corticobasal syndrome…
  • MDS Virtual Congress 2020

    Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy

    E. Bayram, J. Jankovic, S. Reich, C. Marras, Y. Bordelon, D. Shprecher, R. Dubinsky, I. Litvan (La Jolla, CA, USA)

    Objective: (1) To evaluate the cognitive differences between men and women with progressive supranuclear palsy (PSP) and (2) to investigate whether sex has an effect…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An atypical and interesting feature of Parkinson´s disease
  • #24475 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley